Related Experiment Video
Updated: Jan 20, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
[Cardiac involvement in neurological diseases].
1Medizinische Klinik - Schwerpunkt Kardiologie und Internistische Intensivmedizin, Klinikum Würzburg Mitte - Standort Juliusspital, Salvatorstr. 7, 97074, Würzburg, Deutschland. M.Meesmann@kwm-klinikum.de.
Neurological diseases can significantly impact heart health, sometimes triggering cardiac conditions. Brain imaging is crucial for diagnosing cardiac disease, as an underlying neurological disorder may be the cause.
Area of Science:
- Neurology
- Cardiology
- Neurocardiology
Background:
- Cardiac diseases can manifest neurological complications.
- Conversely, primary neurological disorders can adversely affect cardiac function.
- Understanding this bidirectional relationship is critical for comprehensive patient care.
Purpose of the Study:
- To review the impact of primary neurological diseases on the heart.
- To highlight the importance of considering neurological conditions in cardiac disease diagnosis.
- To illustrate the link between undiagnosed neurological disorders and cardiac events.
Main Methods:
- Literature review of neurological diseases affecting the heart.
- Discussion of specific categories: genetic muscular disorders, neurodegenerative diseases, neurological syndromes, and brain disease sequelae.
- Inclusion of a case vignette to demonstrate the clinical connection.
Main Results:
- Various primary neurological conditions can lead to cardiac manifestations.
- Undiagnosed neurological diseases can precipitate cardiac disease.
- The presented case exemplifies the critical link between brain and heart health.
Conclusions:
- Primary neurological diseases pose a significant threat to cardiac health.
- Brain imaging should be a routine consideration in the diagnostic workup of cardiac disease.
- Early identification of neurological disorders is essential to prevent or manage cardiac complications.
More Related Videos
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Related Concept Videos
09:58Lipidomics and Transcriptomics in Neurological Diseases
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:19Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
09:30A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
08:11Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
11:42In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes